Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE)

Clinical trial NCT05001698 · COMPLETED

Trial details

NCT number: NCT05001698
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2021-07-27
Primary completion: 2022-06-02
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.